BIOGEN INC (BIIB)

US09062X1037 - Common Stock

193.18  -0.93 (-0.48%)

Premarket: 205.85 +12.67 (+6.56%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
10.982B
-18.32%		10.173B
-7.37%		9.836B
-3.32%		9.644B
-1.95%
EBITDA
YoY % growth
3.983B
-26.68%		3.742B
-6.03%		2.545B
-32.00%		3.37B
32.43%
EBIT
YoY % growth
3.495B
-29.75%		3.224B
-7.75%		2.05B
-36.42%		2.83B
38.06%
Operating Margin
31.82%31.69%20.84%29.34%
EPS
YoY % growth
19.18
-41.56%		18.45
-3.81%		15.08
-18.27%		15.76
4.52%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		3.51
3.34%
Revenue
Q2Q % growth		2.357B
-4.30%
EBITDA
Q2Q % growth		819.42MN/AN/AN/AN/A
EBIT
Q2Q % growth		651.73M
13.46%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 3.30
-18.52%		3.250.051.62%
Q3 2023
Q2Q % growth		 4.36
-8.60%		4.050.317.59%
Q2 2023
Q2Q % growth		 4.02
-23.43%		3.840.184.66%
Q1 2023
Q2Q % growth		 3.40
-22.37%		3.340.061.66%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 2.386B
-6.20%		2.514B-127.7M-5.08%
Q3 2023
Q2Q % growth		 2.53B
0.87%		2.446B84.3M3.45%
Q2 2023
Q2Q % growth		 2.456B
-5.14%		2.412B44M1.82%
Q1 2023
Q2Q % growth		 2.463B
-2.72%		2.389B74M3.10%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-1.22% -0.31% -0.22% -1.65%
Revenue-0.34% -3.16% -0.21% -2.47%